Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03599388 · ClinicalTrials.gov registry record · NA
Extending Sleep to Reverse Metabolic Syndrome in Middle-aged Adults: Acceptability and Feasibility of a Sleep Intervention
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03599388 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 14 participants.
The verdict
NCT03599388, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This pilot study will test acceptability and feasibility of a sleep extension intervention in community dwelling, short sleeping, racially/ethnically diverse middle aged adults with Metabolic Syndrome (METs). Baseline sleep habits will be assessed and used to guide individualized strategies to extend sleep. A 1-group pre-test, post-test study design will test the efficacy of this 18 week study (2 weeks of baseline data collection, 1 week of study intervention planning, 12 weeks of sleep intervention planning, 12 weeks of sleep intervention delivery, final follow up 3 weeks after last day of the 12 week intervention) on sleep duration, MetS factors (waist circumference, blood pressure, fasting glucose, trigycerides, HDL-c), MetS risk behaviors (poor affective well-being, fatigue) and self regulation. Socio-ecological barriers and facilitators to the intervention will be identified using a quantitative and qualitative approach.
Interventions
- BEHAVIORAL Self- management for adequate sleep intervention (SASI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2019-04-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03599388
The ClinicalTrials.gov registry entry for NCT03599388 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Self- management for adequate sleep intervention (SASI) is the first listed.
NCT03599388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03599388 about?
NCT03599388 is a clinical study titled "Extending Sleep to Reverse Metabolic Syndrome in Middle-aged Adults: Acceptability and Feasibility of a Sleep Intervention". This pilot study will test acceptability and feasibility of a sleep extension intervention in community dwelling, short sleeping, racially/ethnically diverse middle aged adults with Metabolic Syndrome (METs). Baseline sleep habits will be assessed and used to guide individualized strategies to exten...
What is the current status of trial NCT03599388?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2018-11-01. Estimated completion is 2019-04-02.
What interventions are being tested in trial NCT03599388?
The interventions under investigation include: Self- management for adequate sleep intervention (SASI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03599388?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.